Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Score
|
Ref.
|
acc0901 |
p38 |
phosphorylation |
Tyr182 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0902 |
p38 |
phosphorylation |
Tyr182 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0903 |
JNK |
phosphorylation |
Thr183 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0904 |
JNK |
phosphorylation |
Thr183 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0905 |
JNK |
phosphorylation |
Tyr185 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0906 |
JNK |
phosphorylation |
Tyr185 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0907 |
ERK2 |
phosphorylation |
Thr185 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0908 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0909 |
ERK1 |
phosphorylation |
Thr202 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0910 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0911 |
ERK2 |
phosphorylation |
Thr185 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0912 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0913 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
SK-BR-3 |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0914 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
435eB |
Curcumin + Tricostatin A |
Associated |
4.0 |
22290509
|
acc0915 |
RPS6 |
phosphorylation |
Ser235 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29777202
|
acc0916 |
RPS6 |
phosphorylation |
Ser236 |
human |
Melanoma |
A375 |
Dabrafenib |
Impairing |
5.0 |
29777202
|
acc0917 |
RPS6 |
phosphorylation |
Ser235 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29777202
|
acc0918 |
RPS6 |
phosphorylation |
Ser236 |
human |
Melanoma |
A375 |
Trametinib |
Impairing |
5.0 |
29777202
|
acc0919 |
SAMHD1 |
phosphorylation |
Thr592 |
human |
Leukemia |
CD4+ T |
Dasatinib |
Associated |
3.0 |
32828803
|
acc0920 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Lung Cancer |
H2286 |
Dasatinib |
Impairing |
5.0 |
25348954
|
acc0921 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Lung Cancer |
HCC366 |
Dasatinib |
Impairing |
5.0 |
25348954
|
acc0922 |
MET |
phosphorylation |
Tyr1234 |
human |
Lung Cancer |
H2286 |
Dasatinib |
Impairing |
5.0 |
25348954
|
acc0923 |
MET |
phosphorylation |
Tyr1234 |
human |
Lung Cancer |
HCC366 |
Dasatinib |
Impairing |
5.0 |
25348954
|
acc0924 |
MET |
phosphorylation |
Tyr1235 |
human |
Lung Cancer |
H2286 |
Dasatinib |
Impairing |
5.0 |
25348954
|
acc0925 |
MET |
phosphorylation |
Tyr1235 |
human |
Lung Cancer |
HCC366 |
Dasatinib |
Impairing |
5.0 |
25348954
|
acc0926 |
CAMKII |
phosphorylation |
Thr286 |
human |
Colorectal Cancer |
HT29 |
DCA |
Associated |
4.0 |
27086143
|
acc0927 |
EGFR |
phosphorylation |
Tyr845 |
human |
Colorectal Cancer |
HT29 |
DCA |
Associated |
4.0 |
27086143
|
acc0928 |
ERK1 |
phosphorylation |
Thr202 |
human |
Colorectal Cancer |
HT29 |
DCA |
Associated |
4.0 |
27086143
|
acc0929 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Colorectal Cancer |
HT29 |
DCA |
Associated |
4.0 |
27086143
|
acc0930 |
ERK2 |
phosphorylation |
Thr185 |
human |
Colorectal Cancer |
HT29 |
DCA |
Associated |
4.0 |
27086143
|
acc0931 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Colorectal Cancer |
HT29 |
DCA |
Associated |
4.0 |
27086143
|
acc0932 |
AKT |
phosphorylation |
Thr308 |
human |
Prostate Cancer |
PC3 |
delta-T |
Associated |
4.0 |
26465359
|
acc0933 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
NCI-H69 |
Naltrindole |
Associated |
4.0 |
15574783
|
acc0934 |
AKT |
phosphorylation |
Thr308 |
human |
Lung Cancer |
NCI-H69 |
Naltrindole |
Associated |
4.0 |
15574783
|
acc0935 |
AKT |
phosphorylation |
Ser473 |
human |
Hepatocellular Carcinoma |
BEL-7402 |
Forskolin |
Associated |
4.0 |
16177565
|
acc0936 |
AKT |
phosphorylation |
Ser473 |
human |
Hepatocellular Carcinoma |
SMMC-7721 |
Forskolin |
Associated |
4.0 |
16177565
|
acc0937 |
AKT |
phosphorylation |
Thr308 |
human |
Hepatocellular Carcinoma |
BEL-7402 |
Forskolin |
Associated |
4.0 |
16177565
|
acc0938 |
AKT |
phosphorylation |
Thr308 |
human |
Hepatocellular Carcinoma |
SMMC-7721 |
Forskolin |
Associated |
4.0 |
16177565
|
acc0939 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
DU145 |
PHLDA3 OV |
Associated |
3.0 |
34303965
|
acc0940 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
PC3 |
PHLDA3 OV |
Associated |
3.0 |
34303965
|
acc0941 |
GSK3beta |
phosphorylation |
Ser9 |
human |
Prostate Cancer |
DU145 |
PHLDA3 OV |
Associated |
3.0 |
34303965
|
acc0942 |
GSK3beta |
phosphorylation |
Ser9 |
human |
Prostate Cancer |
PC3 |
PHLDA3 OV |
Associated |
3.0 |
34303965
|
acc0943 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
DU145 |
Docetaxel |
Impairing |
5.0 |
34303965
|
acc0944 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
PC3 |
Docetaxel |
Impairing |
5.0 |
34303965
|
acc0945 |
GSK3beta |
phosphorylation |
Ser9 |
human |
Prostate Cancer |
DU145 |
Docetaxel |
Impairing |
5.0 |
34303965
|
acc0946 |
GSK3beta |
phosphorylation |
Ser9 |
human |
Prostate Cancer |
PC3 |
Docetaxel |
Impairing |
5.0 |
34303965
|
acc0947 |
S6 |
phosphorylation |
Ser235 |
human |
Pancreas Cancer |
PANC-1 |
Rapamycin |
Associated |
4.0 |
23437362
|
acc0948 |
S6 |
phosphorylation |
Ser236 |
human |
Pancreas Cancer |
PANC-1 |
Rapamycin |
Associated |
4.0 |
23437362
|
acc0949 |
S6 |
phosphorylation |
Ser235 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Metformin |
Associated |
4.0 |
23437362
|
acc0950 |
S6 |
phosphorylation |
Ser236 |
human |
Pancreas Cancer |
MIA PaCa-2 |
Metformin |
Associated |
4.0 |
23437362
|